Health

National Heart, Lung, and Blood Institute; Notice of Meeting

🇺🇸United States··Notice·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

The law announces an upcoming public meeting of the Sickle Cell Disease Advisory Committee, focusing on nutrition in sickle cell disease. The virtual meeting doesn't require registration and is available to anyone via the NIH videocast. Interested parties can submit written comments in advance.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Announcement of a public meeting
  • Focus on nutrition in sickle cell disease
  • Virtual format without registration requirement

Obligations

What this law requires

medium

Notify the Contact Person (Julie A Panepinto, MD, MSPH) in advance of the meeting if planning to attend and requiring special assistance such as sign language interpretation or other reasonable accommodations

Individuals planning to attend the Sickle Cell Disease Advisory Committee meeting
operational
medium

Post the meeting agenda and additional information on the NHLBI Institute/Center home page (https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/nhlbi-sickle-cell-disease-advisory-committee) when available

National Heart, Lung, and Blood Institute (NHLBI)
disclosure
medium

Make the open session videocast available and accessible via the NIH Videocasting and Podcasting website (https://videocast.nih.gov/watch/d3614358-26f0-11f1-9f14-124f0a52e769)

National Institutes of Health (NIH)
operational
low

Accept written comments from interested persons submitted to the Contact Person, with statements to include the commenter's name, address, telephone number, and when applicable, business or professional affiliation

Sickle Cell Disease Advisory Committee
operational

Affected Parties

Public interested in sickle cell diseaseHealthcare professionals

Tags

health,public meeting,sickle cell disease